ES2190730B1 - PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. - Google Patents
PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS.Info
- Publication number
- ES2190730B1 ES2190730B1 ES200101346A ES200101346A ES2190730B1 ES 2190730 B1 ES2190730 B1 ES 2190730B1 ES 200101346 A ES200101346 A ES 200101346A ES 200101346 A ES200101346 A ES 200101346A ES 2190730 B1 ES2190730 B1 ES 2190730B1
- Authority
- ES
- Spain
- Prior art keywords
- nasal congestion
- pharmaceutical composition
- treat nasal
- congestion via
- via systems
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010028735 Nasal congestion Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- CAVQBDOACNULDN-NRCOEFLKSA-N (1s,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-NRCOEFLKSA-N 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960004159 pseudoephedrine sulfate Drugs 0.000 abstract 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 abstract 1
- 108010011485 Aspartame Proteins 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 239000000619 acesulfame-K Substances 0.000 abstract 1
- 235000019568 aromas Nutrition 0.000 abstract 1
- 239000000605 aspartame Substances 0.000 abstract 1
- 235000010357 aspartame Nutrition 0.000 abstract 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 abstract 1
- 229960003438 aspartame Drugs 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 229960005150 glycerol Drugs 0.000 abstract 1
- 239000000845 maltitol Substances 0.000 abstract 1
- 235000010449 maltitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 229960001855 mannitol Drugs 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composición para tratar la congestión nasal vía sistémica.Composition to treat nasal congestion via systemic
Composición para tratar la congestión nasal, que consiste en incorporar pseudoefedrina sulfato en una forma farmacéutica masticable mediante la cual, durante su ingesta se logra una descongestión nasal por vía sistémica, incorporando goma base, xylitol, manitol, glicerina, jarabe de maltitol, acesulfame K, aspartamo, sulfato de pseudoefedrina, aromas y sorbitol.Composition to treat nasal congestion, which consists of incorporating pseudoephedrine sulfate in a form chewable pharmaceutical by which, during its intake it achieves a nasal decongestion systemically, incorporating gum base, xylitol, mannitol, glycerin, maltitol syrup, acesulfame K, aspartame, pseudoephedrine sulfate, aromas and sorbitol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200101346A ES2190730B1 (en) | 2001-06-11 | 2001-06-11 | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200101346A ES2190730B1 (en) | 2001-06-11 | 2001-06-11 | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2190730A1 ES2190730A1 (en) | 2003-08-01 |
| ES2190730B1 true ES2190730B1 (en) | 2004-12-01 |
Family
ID=27675887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200101346A Expired - Fee Related ES2190730B1 (en) | 2001-06-11 | 2001-06-11 | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2190730B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3389629B1 (en) * | 2015-12-17 | 2021-04-21 | Urgo Recherche Innovation et Développement | Liquid composition for use as a nasal solution |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800083A (en) * | 1986-10-20 | 1989-01-24 | R. P. Scherer Corporation | Sustained release method and product |
| US5560921A (en) * | 1992-06-01 | 1996-10-01 | The Procter & Gamble Company | Chewable decongestant compositions |
| US5681577A (en) * | 1993-06-04 | 1997-10-28 | Warner-Lambert Company | Multiple action cold/sinus preparations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000023046A1 (en) * | 1998-10-16 | 2000-04-27 | Bush Boake Allen Inc. | Chewable or dissolvable pharmaceutical compositions suitable for oral administration |
| CA2366845A1 (en) * | 1999-03-22 | 2000-09-28 | Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. | Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
-
2001
- 2001-06-11 ES ES200101346A patent/ES2190730B1/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4800083A (en) * | 1986-10-20 | 1989-01-24 | R. P. Scherer Corporation | Sustained release method and product |
| US5560921A (en) * | 1992-06-01 | 1996-10-01 | The Procter & Gamble Company | Chewable decongestant compositions |
| US5681577A (en) * | 1993-06-04 | 1997-10-28 | Warner-Lambert Company | Multiple action cold/sinus preparations |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2190730A1 (en) | 2003-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004069198A3 (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
| CL2004000837A1 (en) | INGERIBLE FILM TO ADHER AND DISSOLVE IT IN THE ORAL CAVITY, WHICH INCLUDES A WATER SOLUBLE POLYMER, A SUCRALOSE MASK AND A PHARMACEUTICALLY ACTIVE AGENT. | |
| HRP20160405T1 (en) | Transmucosal delivery devices with enhanced uptake | |
| EP1539069A4 (en) | TRANSMUCTIVE ADMINISTRATION OF CANNABINOIDS | |
| MA27265A1 (en) | OPIOID AGONIST FORMULATIONS WITH RELEASEABLE AND SEQUESTRED ANTAGONIST | |
| BR9607234A (en) | Mucoadhesive granules use the same process for their preparation, pharmaceutical composition and use | |
| DE60225701D1 (en) | OPHTHALMIC DEPOT FORMULATIONS FOR PERIOCULAR OR SUBCONJUNCTIVAL ADMINISTRATION | |
| FR2843117B1 (en) | POLYAMINOACIDS FUNCTIONALIZED BY AT LEAST ONE HYDROPHOBIC GROUP AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS | |
| EE200300106A (en) | A pharmaceutical composition as a systemic analgesic | |
| CY1108678T1 (en) | LIQUID Pills for the Prevention and Treatment of Mucosal Diseases and Disorders | |
| WO2006100075A3 (en) | Use of an artificial sweetener to enhance absorption of nicotine | |
| JP2004505028A5 (en) | ||
| BR0016402A (en) | Method for enhancing skin or mucosal tissue permeability to topically or transdermally administered pharmaceutically or cosmetically active agents | |
| ATE541562T1 (en) | IBUPROFEN SUSPENSION | |
| RU2007127999A (en) | ORAL DISINFECTING PHARMACEUTICAL COMPOSITIONS WITH SENSOR SIGNAL AGENTS | |
| ES2314304T3 (en) | TOPIC PHARMACEUTICAL COMPOSITIONS CONTAINING PROPER NATURAL ACTIVE PRINCIPLES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY PROCESSES OF MUCOSES. | |
| AR036937A1 (en) | CHEATABLE TABLET CONTAINING LISINA | |
| ES2190730B1 (en) | PHARMACEUTICAL COMPOSITION TO TREAT NASAL CONGESTION VIA SYSTEMS. | |
| JP2009503097A5 (en) | ||
| EA200700777A1 (en) | OCTENIDIN-CONTAINING TABLETS FOR DISSEMINATION, INTENDED FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE ORAL CAVITY AND SIPS | |
| AR023138A1 (en) | COMPOSITION FOR MEDICATED GUMS, MANUFACTURING PROCESS AND TABLETS OBTAINED WITH THIS PROCESS | |
| WO2001052896A3 (en) | Compositions with enhanced oral bioavailability | |
| ECSP066385A (en) | MULTIVITAMIN SYRUP FOR CHILDREN OR YOUNG ADULTS | |
| BR9605890A (en) | Physiologically active peptide, purified peptide in dimeric form, acid addition salts, peptide base salts, oral intra-tracheal and nasal dosage forms, pharmaceutical formulation processes for preparing the same to induce an immunomodulatory response in a mammal and to manufacture a peptide | |
| DE10154464B4 (en) | Orally administrable pharmaceutical preparation comprising liposomally encapsulated taxol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20030801 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2190730B1 Country of ref document: ES |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20180928 |